Novartis
Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.
Flexible Media Releases
Campaigns
The Novartis Foundation is convening experts from the global health and anti-leprosy community to discuss the current state of leprosy treatment and...
For over a decade, the Novartis Malaria Initiative has been a pioneer in the fight against malaria. Focused on access, treatment, R&D and capacity...
Novartis is a global healthcare company based in Switzerland that provides solutions to address the evolving needs of patients worldwide.
Novartis recently announced the launch of the Novartis Access Portfolio, a first-of-its-kind portfolio approach in healthcare industry, aiming to...
Building on $10M+ commitments to date, US Foundation is providing up to an additional $15M due to emergence of COVID-19 pandemic and elevated focus on...
Initiatives summarizing efforts from the Novartis US Foundation.
Novartis clinical trial efforts in COVID-19 R&D.
In response to the COVID-19 pandemic in the US, the Novartis US Foundation established a Response Fund, which will provide USD 5 million over a one...